Comstock Inc (NASDAQ: LODE) shares are trading higher by 20.06% to $0.37 Tuesday morning after the company announced its metals recycling subsidiary will sell a facility for gross proceeds of $27 million.
Gainers
VYNE Therapeutics Inc. (NASDAQ: VYNE) rose 82.2% to $0.35 in pre-market trading after the company said first vitiligo patient was dosed in Phase 1a/b clinical trial of novel BET inhibitor VYN201.
Comstock Inc. (NYSE:LODE) (“Comstock” or the “Company”) today announced the consolidation of its properties in the historic Comstock and Silver City mining districts, increasing the